NCT04383444View on ClinicalTrials.gov

Surveillance of Individuals Following SARS-CoV-2 Infection

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

February 10, 2022

Conditions
COVID-19
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT04383444 - Surveillance of Individuals Following SARS-CoV-2 Infection | Biotech Hunter | Biotech Hunter